Cleared Traditional

CARDIO XP (K102767) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K102767 · Bionet Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2011
Decision
252d
Days
Class 2
Risk

K102767 is an FDA 510(k) clearance for the CARDIO XP. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Bionet Co., Ltd. (Irvine, US). The FDA issued a Cleared decision on June 3, 2011 after a review of 252 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Bionet Co., Ltd. devices

Submission Details

510(k) Number K102767 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 24, 2010
Decision Date June 03, 2011
Days to Decision 252 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
127d slower than avg
Panel avg: 125d · This submission: 252d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 128
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K102767.
PC ECG
K160876 · Edan Instruments, Inc. · Feb 2017
CP150 ELECTROCARDIOGRAPH
K131573 · Welch Allyn, Inc. · Jul 2013
QT GUARD PLUS ANALYSIS SYSTEM
K120770 · Ge Medical Systems Information Technologies · Dec 2012
V-TRUST MODEL TD-2202 PORTABLE ECG RECORDER
K101569 · Taidoc Technology Corporation · Mar 2011
MAC 1600 ECG ANALYSIS SYSTEM
K081437 · Ge Medical Systems Information Technologies · Jul 2008
CP100 & 200 12-LEAD RESTING ELECTROCARDIOGRAPHS
K072449 · Welch Allyn, Inc. · Nov 2007